Please login to the form below

Not currently logged in
Email:
Password:

Innovative Medicines Initiative appoints executive director

Pierre Meulien joins from Genome Canada 

edit-Innovative-Medicines-Initiative-pierre-meulienInnovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September.

Meulien is currently president and CEO of Genome Canada, a not-for-profit organisation that aims to find new uses for genomics. At the organisation, he successfully secured funding from the Canadian government and leveraged further funding through partnerships.

Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead the second phase of the Innovative Medicines Initiative. 

“This unique joint venture will deliver health innovations to millions of European citizens and solidify an important industry based in Europe that will be a source of jobs and growth in all of the member states.”

Prior to joining Genome Canada in 2010, Meulien served as CSO for Genome British Columbia, where he promoted the organisation's scientific strategy, and prior to that was founding CEO of the Dublin Molecular Medicine Centre.

Carlos Moedas, European commissioner for research, science and innovation, said: “The excellent results coming out of IMI's projects contribute to improving public health and are stimulating innovation and job creation in Europe. Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”

22nd June 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics